Clinical Trial

Metabolism Imaging-genomics for Predicting the Surgical Outcomes of Colorectal Cancer

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
In this study, the investigators constructed an imaging-metabolism prediction model for colorectal cancer by analysing the imaging and metabolomics features of colorectal cancer, in order to further adjust and guide the treatment plan.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-09-24.
Trial Details
NCT Number NCT06614660
Lead Sponsor First Affiliated Hospital of Chongqing Medical University
Conditions Colorectal Cancer, Imaging, Metabolomics, Prognosis, Genomics
Enrollment 800 participants
Start Date 2024-09-01
Primary Completion 2027-09-01 (estimated)
Study Completion 2027-09-01 (estimated)
Updated on ClinicalTrials.gov 2024-09-27